PMC:7299399 / 15960-16296 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T67","span":{"begin":247,"end":255},"obj":"Disease"}],"attributes":[{"id":"A67","pred":"mondo_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"With unprecedented speed, this extraordinary scientific mobilization led the first vaccine candidate to enter the Phase I human clinical trial on March 16, 2020, and other novel candidates are rapidly following.59 Up to May 22, 2020, there are 10 COVID-19 candidate vaccines in clinical evaluations and 114 in preclinical development.60"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T172","span":{"begin":122,"end":127},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T173","span":{"begin":224,"end":226},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T174","span":{"begin":303,"end":306},"obj":"http://purl.obolibrary.org/obo/CLO_0053001"}],"text":"With unprecedented speed, this extraordinary scientific mobilization led the first vaccine candidate to enter the Phase I human clinical trial on March 16, 2020, and other novel candidates are rapidly following.59 Up to May 22, 2020, there are 10 COVID-19 candidate vaccines in clinical evaluations and 114 in preclinical development.60"}

{"project":"LitCovid-sentences","denotations":[{"id":"T74","span":{"begin":0,"end":336},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"With unprecedented speed, this extraordinary scientific mobilization led the first vaccine candidate to enter the Phase I human clinical trial on March 16, 2020, and other novel candidates are rapidly following.59 Up to May 22, 2020, there are 10 COVID-19 candidate vaccines in clinical evaluations and 114 in preclinical development.60"}

{"project":"LitCovid-PubTator","denotations":[{"id":"253","span":{"begin":122,"end":127},"obj":"Species"},{"id":"255","span":{"begin":247,"end":255},"obj":"Disease"}],"attributes":[{"id":"A253","pred":"tao:has_database_id","subj":"253","obj":"Tax:9606"},{"id":"A255","pred":"tao:has_database_id","subj":"255","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"With unprecedented speed, this extraordinary scientific mobilization led the first vaccine candidate to enter the Phase I human clinical trial on March 16, 2020, and other novel candidates are rapidly following.59 Up to May 22, 2020, there are 10 COVID-19 candidate vaccines in clinical evaluations and 114 in preclinical development.60"}